Fig. 3From: Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariablesPre-Audencel ELISPOT Granzyme B. a Example readout. b Granzyme B correlated with survival (p = 0.007, n = 17). c Significant survival curve separation (p = 0.006, n = 17)Back to article page